Caveolin-1 (CAV1) is a negative regulator of NOX2 in the normal pulmonary circulation and genetic ablation of CAV1 increases NOX2 expression and activity and worsens pulmonary hypertension [73]. The gene discussed is CYBB; the disease is pulmonary arterial hypertension.